16 results on '"B. Sattler"'
Search Results
2. Entwicklung eines Non-Uniform Rational Basis-Spline (NURBS) Phantoms vom Schwein für die präklinische Inkorporationsdosimetrie
- Author
-
O. Roesner, S. Lamart, M. Rullmann, B. Sattler, and O. Sabri
- Published
- 2022
3. Quality control in PET/CT and PET/MRI: results of an EFOMP survey amongst Europe
- Author
-
G. Reynés-Llompart, A. Zorz, R. Boellaard, P. Jaroslav, R. Matheoud, L. Pike, M. Soret, S. Vandenberghe, K. Dalianis, P.M. Dinis De Almeida, C. Fabbri, J. Gawel, P. Hadjitheodorou, P. Julyan, M. Kotzasarlidou, T.V.M. Lima, J. O’Doherty, I. Rausch, M. Sanchez-Garcia, B. Sattler, K. Skovorodko, D. Sutov, A. Taher, G. Tosi, M. Valenti, and E. Vanzi
- Subjects
Biophysics ,General Physics and Astronomy ,Radiology, Nuclear Medicine and imaging ,General Medicine - Published
- 2021
4. From remote to urbanized: Dispersal of antibiotic-resistant bacteria under the aspect of anthropogenic influence.
- Author
-
Gattinger D, Schlenz V, Weil T, and Sattler B
- Subjects
- Humans, Drug Resistance, Microbial, Ecosystem, Anti-Bacterial Agents pharmacology, Bacteria
- Abstract
Antibiotic resistance is a growing global concern, but our understanding of the spread of resistant bacteria in remote regions remains limited. While some level of intrinsic resistance likely contributes to reduced susceptibility to antimicrobials in the environment, it is evident that human actions, particularly the (mis)use of antibiotics, play a significant role in shaping the environmental resistome, even in seemingly distant habitats like glacier ice sheets. Our research aims to bridge this knowledge gap by investigating the direct influence of human activities on the presence of antibiotic-resistant bacteria in various habitats. To achieve a comprehensive assessment of anthropogenic impact across diverse and seemingly isolated sampling sites, we developed an innovative approach utilizing Corine Land Cover data and heatmaps generated from sports activity trackers. This method allowed us to make meaningful comparisons across relatively pristine environments. Our findings indicate a noteworthy increase in culturable antibiotic-resistant bacteria with heightened human influence, as evidenced by our analysis of glacier, snow, and lake water samples. Notably, the most significant concentrations of antibiotic-resistant and multidrug-resistant microorganisms were discovered in two highly impacted sampling locations, namely the Tux Glacier and Gas Station Ellmau., Competing Interests: Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Daniel Gattinger reports financial support was provided by University of Innsbruck. Birgit Sattler reports financial support was provided by Tawani Foundation. Tobias Weil reports financial support was provided by Autonomous Province of Trento. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
5. EFOMP policy statement NO. 19: Dosimetry in nuclear medicine therapy - Molecular radiotherapy.
- Author
-
Sjögreen-Gleisner K, Flux G, Bacher K, Chiesa C, de Nijs R, Kagadis GC, Lima T, Georgosopoulou ML, Gabiña PM, Nekolla S, Peters S, Santos J, Sattler B, Stokke C, Tran-Gia J, Gilligan P, and Bardiès M
- Subjects
- Humans, Radiometry, Policy, Europe, Nuclear Medicine
- Abstract
The European Council Directive 2013/59/Euratom (BSS Directive) includes optimisation of treatment with radiotherapeutic procedures based on patient dosimetry and verification of the absorbed doses delivered. The present policy statement summarises aspects of three directives relating to the therapeutic use of radiopharmaceuticals and medical devices, and outlines the steps needed for implementation of patient dosimetry for radioactive drugs. To support the transition from administrations of fixed activities to personalised treatments based on patient-specific dosimetry, EFOMP presents a number of recommendations including: increased networking between centres and disciplines to support data collection and development of codes-of-practice; resourcing to support an infrastructure that permits routine patient dosimetry; research funding to support investigation into individualised treatments; inter-disciplinary training and education programmes; and support for investigator led clinical trials. Close collaborations between the medical physicist and responsible practitioner are encouraged to develop a similar pathway as is routine for external beam radiotherapy and brachytherapy. EFOMP's policy is to promote the roles and responsibilities of medical physics throughout Europe in the development of molecular radiotherapy to ensure patient benefit. As the BSS directive is adopted throughout Europe, unprecedented opportunities arise to develop informed treatments that will mitigate the risks of under- or over-treatments., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2023 Associazione Italiana di Fisica Medica e Sanitaria. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
6. Editorial: Women in extreme microbiology: 2022.
- Author
-
Sattler B and Sharma M
- Abstract
Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
- Published
- 2023
- Full Text
- View/download PDF
7. International EANM-SNMMI-ISMRM consensus recommendation for PET/MRI in oncology.
- Author
-
Veit-Haibach P, Ahlström H, Boellaard R, Delgado Bolton RC, Hesse S, Hope T, Huellner MW, Iagaru A, Johnson GB, Kjaer A, Law I, Metser U, Quick HH, Sattler B, Umutlu L, Zaharchuk G, and Herrmann K
- Abstract
Preamble: The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is an international scientific and professional organization founded in 1954 to promote the science, technology, and practical application of nuclear medicine. The European Association of Nuclear Medicine (EANM) is a professional non-profit medical association that facilitates communication worldwide between individuals pursuing clinical and research excellence in nuclear medicine. The EANM was founded in 1985. The merged International Society for Magnetic Resonance in Medicine (ISMRM) is an international, nonprofit, scientific association whose purpose is to promote communication, research, development, and applications in the field of magnetic resonance in medicine and biology and other related topics and to develop and provide channels and facilities for continuing education in the field.The ISMRM was founded in 1994 through the merger of the Society of Magnetic Resonance in Medicine and the Society of Magnetic Resonance Imaging. SNMMI, ISMRM, and EANM members are physicians, technologists, and scientists specializing in the research and practice of nuclear medicine and/or magnetic resonance imaging. The SNMMI, ISMRM, and EANM will periodically define new guidelines for nuclear medicine practice to help advance the science of nuclear medicine and/or magnetic resonance imaging and to improve the quality of service to patients throughout the world. Existing practice guidelines will be reviewed for revision or renewal, as appropriate, on their fifth anniversary or sooner, if indicated. Each practice guideline, representing a policy statement by the SNMMI/EANM/ISMRM, has undergone a thorough consensus process in which it has been subjected to extensive review. The SNMMI, ISMRM, and EANM recognize that the safe and effective use of diagnostic nuclear medicine imaging and magnetic resonance imaging requires specific training, skills, and techniques, as described in each document. Reproduction or modification of the published practice guideline by those entities not providing these services is not authorized. These guidelines are an educational tool designed to assist practitioners in providing appropriate care for patients. They are not inflexible rules or requirements of practice and are not intended, nor should they be used, to establish a legal standard of care. For these reasons and those set forth below, the SNMMI, the ISMRM, and the EANM caution against the use of these guidelines in litigation in which the clinical decisions of a practitioner are called into question. The ultimate judgment regarding the propriety of any specific procedure or course of action must be made by the physician or medical physicist in light of all the circumstances presented. Thus, there is no implication that an approach differing from the guidelines, standing alone, is below the standard of care. To the contrary, a conscientious practitioner may responsibly adopt a course of action different from that set forth in the guidelines when, in the reasonable judgment of the practitioner, such course of action is indicated by the condition of the patient, limitations of available resources, or advances in knowledge or technology subsequent to publication of the guidelines. The practice of medicine includes both the art and the science of the prevention, diagnosis, alleviation, and treatment of disease. The variety and complexity of human conditions make it impossible to always reach the most appropriate diagnosis or to predict with certainty a particular response to treatment. Therefore, it should be recognized that adherence to these guidelines will not ensure an accurate diagnosis or a successful outcome. All that should be expected is that the practitioner will follow a reasonable course of action based on current knowledge, available resources, and the needs of the patient to deliver effective and safe medical care. The sole purpose of these guidelines is to assist practitioners in achieving this objective., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
8. Using Fume Hood to Reduce Nurses' Exposure to Particulate Matters Dispersed Into the Air During Pill Crushing.
- Author
-
Amiri A, Guess L, Gilder R, Showalter D, Hart L, and Sattler B
- Subjects
- Humans, Particulate Matter, Ventilation, Air Movements, Gases, Dust, Occupational Exposure prevention & control, Occupational Exposure analysis, Air Pollution, Indoor prevention & control, Air Pollution, Indoor analysis, Nurses
- Abstract
Background: Pill crushing is a common practice in patient care settings. Crushing pills can disperse particulate matter (PM) into indoor air. The PM is a widespread air pollutant composed of microscopic particles and droplets of various sizes and may carry active and/or inactive ingredients nurses can inhale. This study aimed to quantify PM sizes and concentration in indoor air when pills are crushed and examine the role of a fume hood in reducing particulate pollution., Methods: Two scenarios (with and without a fume hood) representing nurses' pill-crushing behaviors were set up in a positive-pressure cleanroom. Two acetaminophen tablets (325 mg/tablet) were crushed into powder and mixed with unsweetened applesauce. The PM sizes and concentrations were measured before and during crushing., Results: Different sizes of PM, including inhalable, respirable, and thoracic particles, were emitted during medication crushing. The total count of all particle sizes and mass concentrations of particles were significantly lower during crushing when a fume hood was used ( p = .00)., Conclusion: Pill crushing increases PM and should be considered a workplace safety health hazard for nurses. Healthcare professionals should work under a fume hood when crushing pills and wear proper protective equipment. The findings of significant particulate pollution related to pill crushing suggest that further research is warranted.
- Published
- 2023
- Full Text
- View/download PDF
9. A comparative approach to confirm antibiotic-resistant microbes in the cryosphere.
- Author
-
Gattinger D, Pichler K, Weil T, and Sattler B
- Abstract
Antibiotic-resistant microbes pose one of the biggest challenges of the current century. While areas with proximity to human impact are closely studied, a lot is yet to learn about antimicrobial resistance in remote regions like the cryosphere. Nowadays, antibiotic (AB) resistance is considered a pollution that has reached the Earth's most pristine areas. However, monitoring of resistant environmental bacteria therein faces several challenges that inhibit scientific progress in this field. Due to many cultivation-based antibiotic susceptibility tests being optimized for mesophilic pathogenic microorganisms, many researchers opt for expensive molecular biological approaches to detect antibiotic resistance in the cryosphere. However, some disadvantages of these methods prohibit effective comprehensive monitoring of resistant bacteria in pristine areas, hence we suggest established cultivation-based approaches when looking for antimicrobial resistance in the cryosphere. In this study, we compared two common antibiotic susceptibility tests and optimized them to meet the needs of psychrophilic microorganisms. The resulting cultures thereof originated from cryospheric habitats with differing anthropogenic impacts. The results show that these methods are applicable to detect antibiotic resistance in cryospheric habitats and could potentially increase the comparability between studies., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Gattinger, Pichler, Weil and Sattler.)
- Published
- 2023
- Full Text
- View/download PDF
10. EANM guidelines for PET-CT and PET-MR routine quality control.
- Author
-
Koole M, Armstrong I, Krizsan AK, Stromvall A, Visvikis D, Sattler B, Nekolla SG, and Dickson J
- Subjects
- Positron-Emission Tomography methods, Quality Control, Phantoms, Imaging, Positron Emission Tomography Computed Tomography, Nuclear Medicine
- Abstract
We present guidelines by the European Association of Nuclear Medicine (EANM) for routine quality control (QC) of PET-CT and PET-MR systems. These guidelines are partially based on the current EANM guidelines for routine quality control of Nuclear Medicine instrumentation but focus more on the inherent multimodal aspect of the current, state-of-the-art PET-CT and PET-MR scanners. We briefly discuss the regulatory context put forward by the International Electrotechnical Commission (IEC) and European Commission (EC) and consider relevant guidelines and recommendations by other societies and professional organizations. As such, a comprehensive overview of recommended quality control procedures is provided to ensure the optimal operational status of a PET system, integrated with either a CT or MR system. In doing so, we also discuss the rationale of the different tests, advice on the frequency of each test and present the relevant MR and CT tests for an integrated system. In addition, we recommend a scheme of preventive actions to avoid QC tests from drifting out of the predefined range of acceptable performance values such that an optimal performance of the PET system is maintained for routine clinical use., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2022. Published by Elsevier GmbH.)
- Published
- 2023
- Full Text
- View/download PDF
11. EFOMP's protocol quality controls in PET/CT and PET/MR.
- Author
-
Matheoud R, Boellaard R, Pike L, Ptacek J, Reynés-Llompart G, Soret M, Vandenberghe S, Zorz A, Julyan P, Rausch I, Sattler B, Manuel SG, Tosi G, Dalianis K, Almeida PMD, Fabbri C, Gawel J, Hadjitheodorou P, Kotzasarlidou M, Viana Miranda Lima T, O'Doherty J, Skovorodko K, Sutov D, Taher A, Valenti M, and Vanzi E
- Subjects
- Humans, Positron-Emission Tomography methods, Magnetic Resonance Imaging methods, Quality Control, Image Processing, Computer-Assisted methods, Positron Emission Tomography Computed Tomography, Multimodal Imaging methods
- Abstract
This article presents the protocol on Quality Controls in PET/CT and PET/MRI published online in May 2022 by the European Federation of Organisations for Medical Physics (EFOMP), which was developed by the Working group for PET/CT and PET/MRI Quality Control (QC) protocol. The main objective of this protocol was to comprehensively provide simple and practical procedures that may be integrated into clinical practice to identify changes in the PET/CT/MRI system's performance and avoid short- and long-term quality deterioration. The protocol describes the quality control procedures on radionuclide calibrators, weighing scales, PET, CT and MRI systems using selected and measurable parameters that are directly linked to clinical images quality. It helps to detect problems before they can impact clinical studies in terms of safety, image quality, quantification accuracy and patient radiation dose. CT and MRI QCs are described only in the context of their use for PET (attenuation correction and anatomical localization) imaging. Detailed step-by-step instructions have been provided, limiting any misinterpretations or interpersonal variations as much as possible. This paper presents the main characteristics of the protocol illustrated together with a brief summary of the content of each chapter. A regular QC based on the proposed protocol would guarantee that PET/CT and PET/MRI systems operate under optimal conditions, resulting in the best performance for routine clinical tasks., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2022 Associazione Italiana di Fisica Medica e Sanitaria. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
12. Editorial: Digitizing frozen earth-revealing microbial diversity and physiology in the cryobiosphere through "omics" tools, volume II.
- Author
-
Jungblut AD, Velazquez D, Cirés S, Kleinteich J, Kottekkatu Padinchati K, Sattler B, and Comte J
- Abstract
Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
- Published
- 2022
- Full Text
- View/download PDF
13. Investigation of Shear Strength and Microstructure Formation of Joined Ni Superalloys Using Ni Nanopastes.
- Author
-
Sattler B, Hausner S, and Wagner G
- Abstract
By using Ni nanoparticles, the bonding of Ni base superalloys can be achieved with shear strengths well above 200 MPa in a joining process at comparatively low temperatures between 675 °C and 975 °C. This is enabled due to the high surface-to-volume ratio of nanoparticles, which leads to distinctly lower melting and sintering temperatures than those of the corresponding bulk material. The nanoparticles in this study are employed in high-metal nanopastes, whereby different chemical compositions of the pastes and different sizes of Ni nanoparticles were investigated. The results for the joining of Ni base superalloys showed that both size and composition had a significant influence on the achievable strengths. In addition, an extensive examination was conducted to reveal the influence of the process parameters joining temperature, holding time and joining pressure on the shear strengths as well as microstructure. It was shown that the temperature exerted the most influence on the strengths and the microstructure. The joining pressure also had a significant influence. The holding time, on the other hand, did not have a major influence on the strengths and in some cases even showed an unexpected behavior, as the values decreased for some combinations with longer holding time.
- Published
- 2022
- Full Text
- View/download PDF
14. Quantitation of the A 2A Adenosine Receptor Density in the Striatum of Mice and Pigs with [ 18 F]FLUDA by Positron Emission Tomography.
- Author
-
Gündel D, Toussaint M, Lai TH, Deuther-Conrad W, Cumming P, Schröder S, Teodoro R, Moldovan RP, Pan-Montojo F, Sattler B, Kopka K, Sabri O, and Brust P
- Abstract
The cerebral expression of the A
2A adenosine receptor (A2A AR) is altered in neurodegenerative diseases such as Parkinson's (PD) and Huntington's (HD) diseases, making these receptors an attractive diagnostic and therapeutic target. We aimed to further investigate the pharmacokinetic properties in the brain of our recently developed A2A AR-specific antagonist radiotracer [18 F]FLUDA. For this purpose, we retrospectively analysed dynamic PET studies of healthy mice and rotenone-treated mice, and conducted dynamic PET studies with healthy pigs. We performed analysis of mouse brain time-activity curves to calculate the mean residence time (MRT) by non-compartmental analysis, and the binding potential ( BPND ) of [18 F]FLUDA using the simplified reference tissue model (SRTM). For the pig studies, we performed a Logan graphical analysis to calculate the radiotracer distribution volume ( VT ) at baseline and under blocking conditions with tozadenant. The MRT of [18 F]FLUDA in the striatum of mice was decreased by 30% after treatment with the A2A AR antagonist istradefylline. Mouse results showed the highest BPND (3.9 to 5.9) in the striatum. SRTM analysis showed a 20% lower A2A AR availability in the rotenone-treated mice compared to the control-aged group. Tozadenant treatment significantly decreased the VT (14.6 vs. 8.5 mL · g-1 ) and BPND values (1.3 vs. 0.3) in pig striatum. This study confirms the target specificity and a high BPND of [18 F]FLUDA in the striatum. We conclude that [18 F]FLUDA is a suitable tool for the non-invasive quantitation of altered A2A AR expression in neurodegenerative diseases such as PD and HD, by PET.- Published
- 2022
- Full Text
- View/download PDF
15. Technical note: A PET/MR coil with an integrated, orbiting 511 keV transmission source for PET/MR imaging validated in an animal study.
- Author
-
Renner A, Rausch I, Cal Gonzalez J, Laistler E, Moser E, Jochimsen T, Sattler T, Sabri O, Beyer T, Figl M, Birkfellner W, and Sattler B
- Subjects
- Animals, Image Processing, Computer-Assisted methods, Magnetic Resonance Imaging methods, Phantoms, Imaging, Positron-Emission Tomography methods, Swine, Artificial Intelligence, Multimodal Imaging methods
- Abstract
Background: MR-based methods for attenuation correction (AC) in PET/MRI either neglect attenuation of bone, or use MR-signal derived information about bone, which leads to a bias in quantification of tracer uptake in PET. In a previous study, we presented a PET/MRI specific MR coil with an integrated transmission source (TX) system allowing for direct measurement of attenuation. In phantom measurements, this system successfully reproduced the linear attenuation coefficient of water., Purpose: The purpose of this study is to validate the TX system in a clinical setting using animals and to show its applicability compared to standard clinical methods., Methods: As test subject, a 15-kg piglet was injected with 53 MBq of 18F-NaF. The μ-map obtained with the TX system and the reconstructed activity distribution were compared to four established AC methods: a Dixon sequence, an ultra-short echo time (UTE) sequence, a CT scan, and a 511 keV transmission scan using a Siemens ECAT EXACT HR+ as the reference. The PET/MRI measurements were performed on a Siemens Biograph mMR to obtain the μ-map using the TX system as well as the Dixon and UTE sequence directly followed by the CT and ECAT measurements., Results: The reconstructed activity distribution using the TX system for AC showed similar results compared to the reference (<5% difference in hot regions) and outperformed the MR-based methods as implemented in the PET/MRI system (<10% difference in hot regions). However, the additional hardware of the TX system adds complexity to the acquisition process., Conclusion: Our porcine study demonstrates the feasibility of post-injection transmission scans using the developed TX system in a clinical setting. This makes it a useful tool for PET/MRI in cases where transmission information is needed for AC. Potential applications are studies using larger animals where state-of-the-art atlas-based or artificial intelligence AC methods are not available., (© 2022 The Authors. Medical Physics published by Wiley Periodicals LLC on behalf of American Association of Physicists in Medicine.)
- Published
- 2022
- Full Text
- View/download PDF
16. Evaluating different methods of MR-based motion correction in simultaneous PET/MR using a head phantom moved by a robotic system.
- Author
-
Einspänner E, Jochimsen TH, Harries J, Melzer A, Unger M, Brown R, Thielemans K, Sabri O, and Sattler B
- Abstract
Background: Due to comparatively long measurement times in simultaneous positron emission tomography and magnetic resonance (PET/MR) imaging, patient movement during the measurement can be challenging. This leads to artifacts which have a negative impact on the visual assessment and quantitative validity of the image data and, in the worst case, can lead to misinterpretations. Simultaneous PET/MR systems allow the MR-based registration of movements and enable correction of the PET data. To assess the effectiveness of motion correction methods, it is necessary to carry out measurements on phantoms that are moved in a reproducible way. This study explores the possibility of using such a phantom-based setup to evaluate motion correction strategies in PET/MR of the human head., Method: An MR-compatible robotic system was used to generate rigid movements of a head-like phantom. Different tools, either from the manufacturer or open-source software, were used to estimate and correct for motion based on the PET data itself (SIRF with SPM and NiftyReg) and MR data acquired simultaneously (e.g. MCLFIRT, BrainCompass). Different motion estimates were compared using data acquired during robot-induced motion. The effectiveness of motion correction of PET data was evaluated by determining the segmented volume of an activity-filled flask inside the phantom. In addition, the segmented volume was used to determine the centre-of-mass and the change in maximum activity concentration., Results: The results showed a volume increase between 2.7 and 36.3% could be induced by the experimental setup depending on the motion pattern. Both, BrainCompass and MCFLIRT, produced corrected PET images, by reducing the volume increase to 0.7-4.7% (BrainCompass) and to -2.8-0.4% (MCFLIRT). The same was observed for example for the centre-of-mass, where the results show that MCFLIRT (0.2-0.6 mm after motion correction) had a smaller deviation from the reference position than BrainCompass (0.5-1.8 mm) for all displacements., Conclusions: The experimental setup is suitable for the reproducible generation of movement patterns. Using open-source software for motion correction is a viable alternative to the vendor-provided motion-correction software., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.